FDA sees high vacancy rates for drug manufacturer inspectors
Update: 2024-11-14
Description
The Food and Drug Administration is having trouble retaining employees who inspect drug manufacturers. The vacancy rate for these FDA investigators nearly doubled between November 2021 and June 2024. The agency tells the Government Accountability Office that travel … pay … and work-life balance are contributing factors to turnover. Investigators can spend up to 75% of their work hours on travel. The FDA paused many inspections of drug manufacturing facilities height of the COVID-19 pandemic.
Learn more about your ad choices. Visit podcastchoices.com/adchoices
Comments
Top Podcasts
The Best New Comedy Podcast Right Now – June 2024The Best News Podcast Right Now – June 2024The Best New Business Podcast Right Now – June 2024The Best New Sports Podcast Right Now – June 2024The Best New True Crime Podcast Right Now – June 2024The Best New Joe Rogan Experience Podcast Right Now – June 20The Best New Dan Bongino Show Podcast Right Now – June 20The Best New Mark Levin Podcast – June 2024
In Channel